Gossamer Bio, Inc. (GOSS)
NASDAQ: GOSS · Real-Time Price · USD
2.670
+0.030 (1.14%)
Jan 28, 2026, 9:10 AM EST - Market open
Gossamer Bio Market Cap
Gossamer Bio has a market cap or net worth of $617.99 million as of January 28, 2026. Its market cap has increased by 180.54% in one year.
Market Cap
617.99M
Enterprise Value
633.70M
1-Year Change
180.54%
Ranking
Category
Stock Price
$2.67
Market Cap Chart
Since February 8, 2019, Gossamer Bio's market cap has decreased from $995.26M to $617.99M, a decrease of -37.91%. That is a compound annual growth rate of -6.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 27, 2026 | 611.04M | -14.84% |
| Dec 31, 2025 | 717.51M | 250.03% |
| Dec 31, 2024 | 204.99M | -0.34% |
| Dec 29, 2023 | 205.69M | 0.56% |
| Dec 30, 2022 | 204.54M | -76.06% |
| Dec 31, 2021 | 854.34M | 21.87% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MeiraGTx Holdings | 643.93M |
| ProKidney | 643.79M |
| LENZ Therapeutics | 631.43M |
| Alpha Tau Medical | 624.99M |
| Altimmune | 617.82M |
| Evommune | 617.24M |
| CorMedix | 611.40M |
| Design Therapeutics | 595.84M |